Characterization of the developmental landscape of murine RORγt+ iNKT cells.


Journal

International immunology
ISSN: 1460-2377
Titre abrégé: Int Immunol
Pays: England
ID NLM: 8916182

Informations de publication

Date de publication:
07 02 2020
Historique:
received: 19 03 2019
accepted: 26 09 2019
pubmed: 1 10 2019
medline: 2 10 2020
entrez: 1 10 2019
Statut: ppublish

Résumé

Invariant natural killer T (iNKT) cells expressing the retinoic acid receptor-related orphan receptor γt (RORγt) and producing IL-17 represent a minor subset of CD1d-restricted iNKT cells (iNKT17) in C57BL/6J (B6) mice. We aimed in this study to define the reasons for their low distribution and the sequence of events accompanying their normal thymic development. We found that RORγt+ iNKT cells have higher proliferation potential and a greater propensity to apoptosis than RORγt- iNKT cells. These cells do not likely reside in the thymus indicating that thymus emigration, and higher apoptosis potential, could contribute to RORγt+ iNKT cell reduced thymic distribution. Ontogeny studies suggest that mature HSAlow RORγt+ iNKT cells might develop through developmental stages defined by a differential expression of CCR6 and CD138 during which RORγt expression and IL-17 production capabilities are progressively acquired. Finally, we found that RORγt+ iNKT cells perceive a strong TCR signal that could contribute to their entry into a specific 'Th17 like' developmental program influencing their survival and migration. Overall, our study proposes a hypothetical thymic developmental sequence for iNKT17 cells, which could be of great use to study molecular mechanisms regulating this developmental program.

Identifiants

pubmed: 31565740
pii: 5576009
doi: 10.1093/intimm/dxz064
doi:

Substances chimiques

Nuclear Receptor Subfamily 1, Group F, Member 3 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

105-116

Informations de copyright

© The Japanese Society for Immunology. 2019. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Auteurs

Jihene Klibi (J)

INSERM, UMR-1160, Institut Universitaire d'Hématologie, Paris, France.
Université Paris Diderot, Sorbonne Paris Cité, Paris, France.

Shamin Li (S)

INSERM, UMR-1160, Institut Universitaire d'Hématologie, Paris, France.
Université Paris Diderot, Sorbonne Paris Cité, Paris, France.

Ludivine Amable (L)

INSERM, UMR-1160, Institut Universitaire d'Hématologie, Paris, France.
Université Paris Diderot, Sorbonne Paris Cité, Paris, France.

Claudine Joseph (C)

INSERM, UMR-1160, Institut Universitaire d'Hématologie, Paris, France.
Université Paris Diderot, Sorbonne Paris Cité, Paris, France.

Stéphane Brunet (S)

INSERM, UMR-1160, Institut Universitaire d'Hématologie, Paris, France.
Université Paris Diderot, Sorbonne Paris Cité, Paris, France.

Marc Delord (M)

Plateforme de Bioinformatique et Biostatistique, Institut Universitaire d'Hématologie, Université Paris Diderot, Sorbonne Paris Cité, Paris, France.

Veronique Parietti (V)

Université Paris Diderot, Sorbonne Paris Cité, Paris, France.
Département d'Expérimentation Animale, Institut Universitaire d'Hématologie, Paris, France.

Jean Jaubert (J)

Mouse Genetics Unit, Institut Pasteur, Paris, France.

Julien Marie (J)

Department of Immunology, Virology and Inflammation, Cancer Research Center of Lyon UMR INSERM1052, CNRS 5286, Centre Léon Bérard Hospital, Université de Lyon, Equipe labellisée LIGUE, Lyon, France.

Saoussen Karray (S)

INSERM, UMR-1160, Institut Universitaire d'Hématologie, Paris, France.
Université Paris Diderot, Sorbonne Paris Cité, Paris, France.

Gerard Eberl (G)

Microenvironment &Immunity Unit, Institut Pasteur, Paris, France.
INSERM U1224, Paris, France.

Bruno Lucas (B)

Institut Cochin, Centre National de la Recherche Scientifique UMR8104, INSERM U1016, Université Paris Descartes, Paris, France.

Antoine Toubert (A)

INSERM, UMR-1160, Institut Universitaire d'Hématologie, Paris, France.
Université Paris Diderot, Sorbonne Paris Cité, Paris, France.

Kamel Benlagha (K)

INSERM, UMR-1160, Institut Universitaire d'Hématologie, Paris, France.
Université Paris Diderot, Sorbonne Paris Cité, Paris, France.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH